Lewes, DE -- (SBWIRE) -- 05/25/2016 -- Global Autoimmune Disease Therapeutics Market is accounted for $51.2 billion in 2015 and is expected to reach $82.13 billion by 2022 growing at a CAGR of 6.9% during the forecast period. Rising healthcare expenditure in the region is one of the key factors fueling the market growth. On the other hand, insufficient funding in emerging countries and high cost involved in the treatment of the disease are hindering the market. Biologics drug acts as initial line of treatment due to therapeutic capabilities in controlling and treatment of different autoimmune complications.

North America is the largest market for autoimmune disease therapeutics due to increasing incidence of different forms of autoimmune disorders, and government initiatives in the region. Europe is expected to be the second largest market due to rising healthcare infrastructure and penetration of new technologies.

Some of the key players in the market include Johnson & Johnson Inc, Bayer Schering Pharma AG, Elan Corporation Plc, Abbott Laboratories, Genentech Inc, GlaxoSmithKline Plc, Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd., Merck & Co. Inc, Amgen Inc, Eli Lilly and Company, F. Hoffmann-La Roche AG, Biogen Idec Inc, Teva Pharmaceuticals, Industries Limited, UCB S.A., Sanofi-Aventis SA, Novartis AG and Shire Plc.

Distribution Channel:
- Drug Stores
- Hospitals
- Independent Pharmacies
- Clinics

Drug Class Covered:
- Anti-Inflammatory Drugs
- Biologics
- Immunosuppressant's
- Nonsteroidal anti-inflammatory drugs
- Corticosteroids

Regions Covered:
- North America
US
Canada
Mexico
- Europe
Germany
France
Italy
UK
Spain
Rest of Europe
- Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
- Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Spanning over 137 pages "Autoimmune Disease Therapeutics - Global Market Outlook (2015-2022)" report covers Executive Summary, Preface, Market Trend Analysis, Porters Five Force Analysis, Global Autoimmune Disease Therapeutics Market, By Distribution Channel, Global Autoimmune Disease Therapeutics Market, By Drug Class, Global Autoimmune Disease Therapeutics Market, By Geography, Key Developments, Company Profiling.

For more information Visit at: http://www.marketresearchreports.com/stratistics-mrc/autoimmune-disease-therapeutics-global-market-outlook-2015-2022

Related Reports:

Pediatric Vaccines - Global Market Outlook (2015-2022); visit at - http://www.marketresearchreports.com/stratistics-mrc/pediatric-vaccines-global-market-outlook-2015-2022

Companion Diagnostics - Global Market Outlook (2015-2022); visit at - http://www.marketresearchreports.com/stratistics-mrc/companion-diagnostics-global-market-outlook-2015-2022

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions